Histologic assessment of dose‐related diffusion and muscle fiber response after therapeutic botulinum a toxin injections

Fiber diameter variability, acetylcholinesterase staining properties, and average fiber diameter were determined 5 weeks after varying doses of botulinum A toxin were administered into albino rabbit longissimus dorsi muscle. The average fiber diameter within the muscle appeared to be a function of the dose of botulinum toxin injected. Fiber diameter variability correlated with the dose of botulinum toxin administered. Both fiber diameter variability and acetylcholinesterase spread characteristics showed a distinct diffusion gradient over a defined field within a muscle. At lower doses (1 IU), collapse of the diffusion gradient occurred over a 15–30‐mm segment of muscle. At higher doses (5–10 IU), diffusion of botulinum A toxin effect occurred throughout the entire muscle with no apparent end point. This study demonstrated that botulinum A toxin produces a gradient of denervation in a given muscle and that both the magnitude of denervation and the extent of the gradient are dose dependent. Furthermore, both muscle fiber diameter variability and acetylcholinesterase staining were useful as measures of chemodenervation.

[1]  L. Duchen Changes in motor innervation and cholinesterase localization induced by botulinum toxin in skeletal muscle of the mouse: differences between fast and slow muscles. , 1970, Journal of neurology, neurosurgery, and psychiatry.

[2]  D. Cozzolino,et al.  Blepharospasm and its treatment, with emphasis on the use of botulinum toxin. , 1989, Plastic and reconstructive surgery.

[3]  D. Musch,et al.  Treatment of blepharospasm with botulinum toxin. A preliminary report. , 1984, Archives of ophthalmology.

[4]  J Jankovic,et al.  Botulinum A toxin for cranial‐cervical dystonia , 1987, Neurology.

[5]  Davide Cozzolino,et al.  Botulinum a toxin for the treatment of spasmodic torticollis: Dysphagia and regional toxin spread , 1990, Head & neck.

[6]  L. Simpson The binding fragment from tetanus toxin antagonizes the neuromuscular blocking actions of botulinum toxin. , 1984, The Journal of pharmacology and experimental therapeutics.

[7]  G. Borodic Botulinum A Toxin for (Expressionistic) Ptosis Overcorrection After Frontalis Sling , 1992, Ophthalmic plastic and reconstructive surgery.

[8]  R. Young,et al.  Innervation Zone of Orbicularis Oculi Muscle and Implications for Botulinum A Toxin Therapy , 1991, Ophthalmic plastic and reconstructive surgery.

[9]  S. Thesleff Supersensitivity of skeletal muscle produced by botulinum toxin , 1960, The Journal of physiology.

[10]  G. Borodic,et al.  Botulinum A Toxin for the Treatment of Adult‐Onset Spasmodic Torticollis , 1991, Plastic and reconstructive surgery.

[11]  L. Pearce,et al.  Botulinum a toxin for spasmodic torticollis: Multiple vs single injection points per muscle , 1992, Head & neck.